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The gastrointestinal tract, is continuously exposed to a wide variety of stimuli, including 
dietary-derived metabolites, environmental compounds and the microbiota. Since these 
antigens can be beneficial or detrimental for the organism, proper sensing of the luminal 
content is essential for orchestrating both pro-inflammatory and tolerogenic immune 
responses on demand and therefore, ensure the establishment of intestinal homeostasis. 
Disruption of these mechanisms might result in inflammation, a characteristic of intestinal 
disorders, such as inflammatory bowel disease (IBD). How environmental triggers modulate 
intestinal inflammation in genetically susceptible host leading to IBD is largely unclear. The 
gap in knowledge around this topic is likely due to the lack of versatile in vivo models 
allowing the testing of a wide variety of compounds in a cost-effective manner. The aim of 
my doctoral thesis was to understand how intestinal inflammation is impacted by genetic 
factors and environmental exposures. 
In study I and II we analyzed how the sensing of dietary-derived metabolites modulate 
immune homeostasis. In study I, we found that retinoic acid receptor a (RARa) signaling in 
intestinal epithelial cells modulated lineage specification of secretory cells and the 
development of the intestinal immune system. Epithelial RARa signaling was essential for 
mounting protective responses against pathogen infection and maintaining intestinal 
homeostasis. In study II, we explored how combinatorial activation of ligand-activated 
transcription factors that sense dietary metabolites in vivo modulate cytokine signaling. We 
found that co-exposure with more than one ligand resulted in activation of the corresponding 
receptors, and in induction of specific cytokine profiles as a result of their interaction. 
In study III, we investigated how GPR35, an IBD-risk gene, modulated intestinal immune 
homeostasis. We found that Gpr35 deficiency in macrophages resulted in exacerbated colitis, 
due to low expression of genes involved in corticosterone synthesis and tumor necrosis factor 
(Tnf). We also identified lysophosphatidic acid as a potential GPR35 ligand that induces Tnf 
expression in macrophages in a GPR35-dependent manner. 
In study IV, we further examined how environmental factors modulate intestinal 
inflammation and found that perfluorooctane sulfonic acid (PFOS), an environmental 
pollutant, exacerbates intestinal inflammation. This was associated with impaired epithelial 
barrier function and systemic T cell responses. 
Taken together, this doctoral thesis provides insight into how environmental and genetic 
factors modulate immune responses contributing to the maintenance of intestinal 
homeostasis. 
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The intestinal tract, as the largest barrier surface in our body, is continuously challenged by a 
wide variety of external and internal insults, including metabolites, microbial products and 
pollutants 8 etc. To distinguish between pathogenic versus innocuous antigens, complex 
interactions between intestinal epithelial cells (IECs), immune and non-immune cells, need to 
be tightly regulated. This ensures inflammatory immune responses against pathogens while 
also inducing tolerance towards innocuous antigens. Failure in maintaining this tight balance 
can lead to aberrant immune responses against commensal or food antigens, a hallmark of 
inflammatory disorders, such as inflammatory bowel disease (IBD) 9. 
1.1 INTESTINAL EPITHELIAL CELLS 
The intestinal epithelium, as a single layer of epithelial cells, also acts as a sensor of 
environmental signals and represents a barrier that protects the host from potentially 
damaging microorganisms and toxic compounds in the luminal content. Unique features of 
the intestinal epithelium, such as its architecture and regional compartmentalization, allow the 
performance of these functions. The intestine is divided mainly in the small intestine and 
colon. The small intestine (SI) is primarily responsible for the digestion and absorption of 
nutrients. The SI epithelial cells are organized in crypts and villi, which are tubular 
invaginations and finger-like protrusions, respectively 10. Conversely, the epithelial lining of 
the colon is devoid of villi, which is responsible for water absorption and compacting the 
stools for rapid excretion 11. 
The epithelial surface from both SI and colon is constantly renewed by pluripotent intestinal 
stem cells (ISCs), which reside in the bottom of the crypts and can give rise to all IEC 
lineages. ISCs have the ability of self-renewal and divide regularly to generate a transit-
amplifying (TA) population of cells that are highly proliferative and differentiate into the 
different IEC types 12. Fully differentiated cells migrate upwards along the villi and are lost at 
the villus tip. This cycle is completed in 3-5 days and is repeated continuously throughout the 
entire lifespan 10. The epithelium of both the small and large intestine contains several 
specialized IEC types, which are briefly described below. 
1.1.1 Secretory cells 
Products secreted by epithelial cells increase the physical barrier between epithelial cells and 
the microbiota, which minimizes their interaction and the risk of bacterial penetration, while 
also regulating a wide variety of responses and modulating immune responses. The secretory 
lineage of IECs includes goblet cells, Paneth cells, enteroendocrine cells and tuft cells, whose 
roles are summarized below. 
Goblet cells are specialized in the secretion of mucus, which provides the first line of defense 
against microbial pathogens and chemical damage 13. In the SI, the mucus consists of an 
easily removable single layer, while in the colon it forms a double layer: a dense inner layer 
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impenetrable to the microbiota, and an outer layer where bacteria can reside. Besides creating 
a physical barrier, the mucus also contains many molecules to control the microbiota 14. 
Paneth cells are located at the base of the crypts and have only been described in the small 
intestine. These cells are essential in limiting pathogen colonization as they produce the 
majority of antimicrobial peptides in the small intestine, including a-defensins, lysozyme, 
phospholipase A2 and ANG4 15. In addition, Paneth cells have a crucial role in the stem cell 
niche as they provide necessary signals for the growth and maintenance of the surrounding 
stem cells, such as Notch ligands 16. Contrary to the other differentiated epithelial cell types, 
Paneth cells are the only ones that migrate down to the bottom of the crypt and are positioned 
in between stem cells, in a process dependent on EphB signaling 17. Notably, Paneth cells 
have a life span of ~57 days, much longer than that of the other secretory cells 18. 
The intestinal epithelium also contains several lineages of enteroendocrine cells (EECs), 
which differ in their location along the gastrointestinal tract and secrete specific hormones. 
EECs sense dietary elements and produce hormones that regulate a wide variety of processes 
19. Finally, tuft cells have long apical microvilli that project into the lumen, in line with their 
chemosensory function 20. Succinate, a metabolic product of pathosymbionts, has been 
recently identified to be sensed by tuft cells and result in their activation 21. Although 
representing a small fraction of intestinal epithelial cells during steady-state conditions, tuft 
cells expand rapidly in response to infection with helminths or protozoa, by producing IL-25 
and promoting type 2 immunity. Upon pathogen sensing, IL-25 production by tuft cells 
stimulates group 2 innate lymphoid cells (ILC2s) in the lamina propria to secrete IL-13, 
which acts on epithelial cell progenitors and results in the hyperplasia of goblet and Tuft cells 
22,23.  
Fate determination of IECs towards the absorptive or secretory lineage is tightly controlled by 
the activity of the Notch pathway 24,25. In addition, differentiation to specific IEC lineages is 
regulated by several transcription factors. Cell specification towards goblet cells is negatively 
regulated by Notch signaling 26, while other transcription factors, including Kruppel-like 
factor 4 (Klf4), promote their differentiation 27. Moreover, the specification towards the 
enteroendocrine cell fate in the intestine is dependent on the transcription factor Neurogenin3 
28,29. The differentiation of Paneth cells requires Sox9 30. Finally, tuft cell differentiation is 
dependent on the transcription factor Pou2f3 31. 
1.1.2 Absorptive cells 
Absorptive enterocytes represent the majority of cells in the intestinal epithelial lining, 
particularly in the villi, produce hydrolytic enzymes that facilitate the digestion and are also 
responsible for nutrient absorption 8. TA cells fated to the absorptive lineage divide several 
times before giving rise to enterocytes 32,33. 
Sampling of the luminal content, especially of microbes, is essential for the maintenance of 
intestinal homeostasis. Microfold (M) cells are specialized IECs that are located in areas of 
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the epithelium that cover lymphoid follicles and transfer luminal antigens to the underlying 
immune cells 32,34. The differentiation of epithelial precursors into M cells is dependent on 
RANKL (receptor-activator of NF-kB ligand), which is expressed by subepithelial stromal 
cells 35. 
1.1.3 Intestinal stem cells 
The intestinal crypts harbor the intestinal stem cells, which give rise to all the lineages of 
epithelial cells. Two pools of ISCs reside in the crypt, with different location and different 
function depending on the context. 
Crypt base columnar (CBC) cells are undifferentiated cells which are continuously cycling 
and are located at the base of the crypt, intercalated with Paneth cells 36. More than 30 years 
after their discovery, leucine-rich-repeat-containing G protein-coupled receptor 5 (Lgr5) was 
identified as the first CBC marker. This allowed lineage-tracing experiments, which showed 
that Lgr5+ CBCs are pluripotent and can give rise to all IEC lineages over time, thus being 
bona fide intestinal stem cells 37. Confirming this, sorted Lgr5+ intestinal stem cells cultured 
in vitro under specific conditions can give rise to “organoids”, structures with the crypt-villus 
architecture characteristic of the intestinal epithelium, where all IEC lineages are present 38. 
While CBCs are located in the crypt base, cells with stem cell attributes located in position 
+4, immediately above the last Paneth cell, were identified by Potten 39. These cells are more 
quiescent but can give rise to all IEC lineages and are considered as a reserve stem cell pool, 
since they can repopulate the Lgr5+ CBCs pool if the latter are eliminated 40,41. Although 
several markers for the population of +4 stem cells, such as Bmi1, Tert, Hopx and Lrig1, have 
been proposed, they are also expressed by Lgr5+ CBCs 40-42. Finally, analysis of the intestinal 
epithelium at the single-cell level identified a population of clusterin+ (Clu+) stem cells 
known as revival stem cells (revSCs) that expand following damage and are required for 
intestinal regeneration 43. Thus, further studies are required to understand the relation between 
the different stem cell pools during homeostasis and regeneration. 
1.2 INTESTINAL IMMUNITY 
Below the epithelial layer lies the lamina propria, a loose connective tissue that contains the 
vast majority of immune cells in the intestine, including myeloid cells and lymphocytes, 
which are briefly described below (Figure 1). 
1.2.1 Myeloid cells 
Mononuclear phagocytes (MNPs): Intestinal MNPs, including macrophages and dendritic 
cells, reside in the lamina propria along the intestinal tract and can also be found in gut-
associated lymphoid tissues (GALT), such as Peyer’s Patches (PPs) and mesenteric lymph 
nodes (MLNs) 44. Under steady-state conditions two populations of MNPs exist in the 
intestinal lamina propria, functionally defined by their expression of CX3CR1 44 or CD64 45. 
CX3CR1+ CD64+ macrophages are located close to the epithelium and are specialized in 
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antigen sampling. These cells are able to directly sample bacteria through dendrites that 
extend to through the epithelial layer without disturbing the intestinal barrier 46, in a 
CX3CR1-dependent manner 47. On the other hand, dendritic cells (DCs) are characterized in 
the intestine by their expression of CD103. These cells are specialized in antigen-presentation 
and activation of T cells 48. CD103+ Dendritic cells can be further subdivided in two major 
subsets that differ in their expression of CD11b and whose ontogeny is dependent on 
different transcription factors 49. Following antigen uptake, CD103+ CD11b- migratory DCs 
are essential for the induction of T cell responses in the draining lymph nodes 50,51. 
Neutrophils: In the event of a bacterial infiltration in host tissues, there are several 
mechanisms to control the bacterial spreading. Microorganisms are rapidly eliminated by 
cells with phagocytic activity, such as neutrophils and macrophages 52. Besides their 
phagocytosis capability, neutrophils are well equipped to limit bacterial translocation through 
the production of reactive oxygen species (ROS), granules with antimicrobial activity and 
formation of neutrophil extracellular traps (NETs) 53,54. Moreover, they are rapidly recruited 
to injured tissues through several signals produced by immune and non-immune cells and can 
further promote the recruitment of other cells by secreting or modifying chemokines and 
cytokines, potentiating the inflammatory conditions 54. After infiltrating tissues, senescent 
neutrophils undergo apoptosis and are engulfed by macrophages, a process that aids in the 
resolution of the acute inflammation 55,56. However, failure in the mechanisms that control 
their removal or apoptosis can lead to accumulation of their cytotoxic products, and result in 
chronic inflammation 57.  
Finally, both neutrophils and macrophages can also promote mucosal healing by producing 
anti-inflammatory mediators that limit further infiltration and growth factors that stimulate 
the proliferation of epithelial cells, respectively 58,59. Thus, understanding the role of myeloid 
cells at different stages of the inflammatory process can aid in the design of therapeutic 
approaches targeting them. 
1.2.2 Lymphocytes 
The gastrointestinal tract contains the largest population of B and T cells in the body and a 
vast network of secondary lymphoid organs, collectively termed as the GALT, where antigen 
presentation takes place 7,60. CD4+ T helper (TH) cells differentiate into several subsets, 
characterized by their expression of cytokines and transcription factors. TH1, TH2 and TH17 
cells orchestrate responses against microorganisms and parasites. On the contrary, regulatory 
T cells (Treg) produce anti-inflammatory cytokines (e.g., IL-10) that suppress unrestrained 
responses and are essential for the development of tolerance against dietary or microbial 
antigens 61. CD8+ T cells are also present in the intestinal mucosa but are mostly found 
among epithelial cells, and prevent the entry of pathogens while restoring the integrity of the 
epithelial barrier 62. Moreover, gd T cells can be found in the intestinal epithelium and lamina 
propria, where they mediate immune responses and limit bacterial penetration 63. 
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Innate lymphoid cells (ILCs) are enriched in mucosal and barrier surfaces, such as the 
gastrointestinal tract. They support tissue homeostasis by orchestrating responses against 
pathogens and promoting the formation of lymph nodes 64,65. ILCs have been classified in 
three subtypes, termed group 1, 2 and 3, (ILC1s, ILC2s and ILC3s, respectively), based on 
their expression of signature cytokines and transcription factors 66. Notably, ILC1s, ILC2s 
and ILC3s share remarkable functional and transcriptional similarity to the TH1, TH2 and 
TH17 subsets, respectively, although their responses are not antigen-specific since they lack 
antigen specific receptors 67. 
Activation of T lymphocytes takes place in the GALT, which maximize the probability of 
events of antigen presentation and subsequent activation. Upon activation, T cells are acquire 
gut-homing capabilities 68, by increasing their expression of the gut-homing markers integrin 
a4b7 and chemokine receptor 9 (CCR9), whose ligands MadCAM-1 and CCL25, 
respectively, are expressed in the lamina propria and by epithelial cells 69,70. 
Regarding humoral responses, antigen-loaded dendritic cells migrate to the GALT and induce 
the differentiation of B cells into IgA-producing plasma cells 71. IgA+ plasma cells then 
migrate to the lamina propria and secrete IgA, which binds the commensal microbiota and 
limits its interaction with the epithelial barrier 72. 
Altogether, several immune cell types with highly specialized functions, are located in the 









1.2.3 Inflammatory Bowel Disease 
Inflammatory bowel disease (IBD), encompassing both ulcerative colitis (UC) and Crohn’s 
disease (CD), is a relapsing and remitting disorder characterized by chronic inflammation of 
the gastrointestinal tract 73. 
Ulcerative colitis (UC) involves inflammation in the colon, which starts in the rectum and can 
spread proximally, affecting it entirely or partially. In contrast, Crohn’s disease (CD) affects 
any region of the gastrointestinal tract, although it involves mostly the ileum and colon, often 
Figure 1. Overview of the intestinal immune system. A 
single layer of epithelial cells separates a wide variety of 
dietary-derived metabolites, microbial products and 
toxins from the host. Highly specialized epithelial cells, 
including goblet cells (GC), secrete products to limit the 
interaction between the microbiota and the host. Most 
intestinal immune cells are located in the lamina propria, 
directly underneath the epithelial cells. Both myeloid 
cells, including macrophages (Mj), dendritic cells (DC) 
and neutrophils, and lymphocytes, such as T cells, innate 
lymphoid cells (ILC) and IgA+ plasma cells, promote the 
maintenance of intestinal homeostasis. Modified from 
Parigi et al., (2015) 7  
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Figure 2. IBD is a multifactorial disease that develops as an active immune response to 
environmental triggers in the context of genetic susceptibility. 
in a discontinuous fashion. While in ulcerative colitis the damage is mostly restricted to the 
mucosa, in Crohn’s disease the inflammation can be transmural, and other complications such 
as strictures and fistulas can be present 73,74. 
The peak of IBD onset is during adolescence and early adult life 75, although people of any 
age can be affected. IBD has been traditionally seen as a disease mostly prevalent in Western 
countries, with more than 1 million IBD patients estimated in the United States, and 
approximately 2.5-3 million estimated in Europe 76,77. However, regions with a traditionally 
low prevalence, such as Africa, South America and Asia, have seen a marked increase in 
incidence in recent decades 78. Hence, with more than 6.8 million patients estimated 
worldwide, and growing incidence in all continents, IBD has become a global disease 79,80.  
The etiology of IBD has not been fully elucidated and it is believed to develop as an active 
immune response in genetically susceptible hosts as a consequence of exposure to microbial 
antigens and environmental triggers 81 (Figure 2). Family history represents a risk factor for 
developing IBD, although the concordance rate in studies in monozygotic twins is only 6-
16% for ulcerative colitis and 35-58% for Crohn’s disease 82,83. Thus, since the contribution 
of genetics in IBD pathogenesis only explains a fraction of disease variability, this suggests 












2 GENETICS IN IBD 
2.1 FAMILIAL AND GENOME-WIDE ASSOCIATION STUDIES (GWAS) IN IBD 
Family-based linkage studies were one of the earliest approaches to identify genetic risk 
factors for complex diseases. This approach had proven to be successful in the mapping of 
Mendelian disease genes, especially for rare diseases such as Huntington’s disease and 
Alzheimer’s disease 84,85. Rare genetic variants that cause IBD-like intestinal inflammation, 
including those found in the IL10RA, IL10RB and IL10 loci, where identified with this 
method 86,87. Missense and nonsense variants in these loci are highly deleterious and have 
large effect sizes, usually leading to a very early onset (VEO) of the disease. These variants 
can result in a disbalance in immune homeostasis by affecting several functions, including 
pathogen clearance, epithelial barrier function and lack of immune inhibitory mechanisms 88.  
In parallel, the advent of genome-wide association studies (GWAS) triggered a remarkable 
shift in our ability to examine the contribution of genetics to diseases, being extremely useful 
in the identification of common variants 89. GWAS focus on the identification of variants that 
are more frequent in the population (5-50%), which usually have small effect sizes. However, 
GWAS are usually not able to distinguish the highly deleterious rare variants described above 
88,90. GWAS usually have large cohort sizes, which allows for the identification of several 
risk loci simultaneously, and to date, more than 200 risk loci have been associated to IBD 91-
105. Since UC and CD share similarities in terms of their pathological features it would be 
expected that they also share several risk loci. Indeed, most of the loci are associated with 
both diseases, although a few have been classified as UC -or CD-specific. This suggests that 
most of the biological mechanisms that are involved in UC are shared to some degree with 
CD and vice versa 103. 
2.2 CHALLENGES IN STUDYING THE GENETIC CONTRIBUTION TO IBD 
Risk loci identified by GWAS contain large clusters of single nucleotide polymorphisms 
(SNPs) that are in linkage disequilibrium. Therefore, it is difficult to distinguish the causal 
SNPs from the neutral variants by just following this approach, especially since the vast 
majority of GWAS hits are located in noncoding regions, with unknown effects. In order to 
identify the causal variants, fine mapping techniques use high-throughput imputations, dense 
genotyping, and methods for statistical refinement, to assign a probability to each variant in a 
locus to be the causal variant of that region being associated to the trait 106. In this sense, a 
study integrating genetic and epigenetic fine mapping analyzing GWAS hits from 21 
autoimmune diseases identified that approximately 90% of the causal variants are indeed 
found in noncoding regions 107. Most of these variants were located in immune-cell enhancers 
and sometimes affecting transcription factors binding sites 107. 
However, assigning a function to variants located in noncoding regions remains a challenge 
due to the incomplete knowledge of the regulatory activity of noncoding elements. Different 
techniques, including the analysis of chromatin openness and histone marks and the 
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prediction of transcription factor binding sites, could provide some information on their 
effect. Further, the study of expression quantitative trait loci (eQTL) can link variants with 
the gene whose expression is affected 108. Combining all these approaches, a fine mapping 
study on selected IBD risk loci found 45 variants with a >50% probability to be the causal 
variant. Coupling the genetics fine mapping with data of expression quantitative trait loci 
(eQTL) and epigenetic marks, allowed them to propose a function for some of these variants 
109. Nevertheless, further research is required to improve our understanding of the regulatory 
activity of noncoding genomic regions. 
Lastly, another significant hurdle is that many of the genes that are implicated through 
GWAS studies have an unknown function or interact in pathways that are not fully 
characterized or with unsuspected relevance in disease pathology 110,111. To bridge this gap, 
the genetic manipulation of animal models will continue to provide important information 
about the functional consequence of individual genes in IBD pathology. 
2.2.1 SNPs in the GPR35 gene 
Among environmental sensors, the large family of G protein-coupled receptors (GPCRs) has 
been recently recognized to be activated by dietary and microbial metabolites. These 
receptors are expressed by different cell types throughout our body and have been shown to 
regulate immune responses and gut homeostasis 112,113. Interestingly, GWAS have identified 
SNPs in GPR35 associated with an increased risk of IBD 102,114. Particularly, among the SNPs 
with the highest association to IBD in this locus, rs3749171 leads to a T108M substitution in 
the protein sequence, which could affect the efficiency of signaling through the receptor 102. 
A challenge in the study of its role in intestinal homeostasis is the lack of bona fide GPR35 
ligands. Although endogenous molecules including kynurenic acid, lysophosphatidic acid 
(LPA) and the chemokine CXCL17 have been reported to activate GPR35 115-117, their 
potency differs between species and it is unclear if they can be produced physiologically at 
concentrations sufficient to activate the receptor 118.  
Interestingly, this receptor is highly expressed by immune cells along the gastrointestinal 
tract, in both humans and mice 117. Functionally, GPR35 is shown to promote the turnover of 
IECs in homeostatic conditions and enhance intestinal tumorigenesis in ApcMin/+ tumor model 
119. On the other hand, impaired GPR35 signaling led to a worsened colitis in mice in the 
DSS model 120. 
In the third manuscript included in this thesis we found that LPA-mediated GPR35 activation 





3 EXPOSOME IN IBD 
The shift in the epidemiology of IBD, with a rapid rise in incidence in areas of the world with 
a traditional low prevalence, hints towards environmental exposures having a predominant 
role in IBD pathogenesis 79. The largest increase in incidence in recent decades are seen in 
newly industrialized countries in Africa, Asia, and South America 121. These regions have 
also seen improved access to health care and better infrastructure to record and study health 
outcomes, which improves the surveillance of IBD incidence globally 79. Although this might 
influence the rise of IBD reported cases, younger immigrants from newly industrialized 
countries to the West have increased risk of developing IBD when exposed to the Western 
environment at an early age 122, thus suggesting that a change in environmental exposures 
might be a critical trigger. 
Besides the shift from an agricultural to a manufacturing industry, societies in these countries 
have also experienced increased migration from rural to urban areas, which has been 
associated with an increased risk for the development of IBD 123. This transition towards a 
more urbanized lifestyle has been accompanied with behavioral changes (e.g. increased 
smoking and more sedentary activities) and alterations in daily exposures (e.g. diet and 
pollutants). Although exposures to these environmental triggers have been associated with 
IBD pathogenesis, their mechanism of action remains vastly unclear. Thus, a better 
understanding of the effect of the “exposome”, defined as the cumulative lifelong 
environmental exposures 124, in IBD, is crucial for reducing the risk of disease incidence or 
patients having a milder clinical course, and for developing therapeutic strategies 125.  
Particularly, early-life exposure to some factors can have long lasting effects in IBD 
pathology. For instance, antibiotic exposure during childhood is associated with a higher risk 
of developing IBD, with the risk increasing with the number of courses of antibiotics used 
126,127. This highlights the impact of an alteration in the normal microbial ecology, termed 
dysbiosis, during the first year of life, a stage where the composition of the gut microbiota is 
established and converges to that found in the adult gastrointestinal tract 125,128. Moreover, 
while the incidence of both pediatric and adult IBD in immigrants from South Asia in Canada 
was lower than that of non-immigrants, second-generation immigrants were at a similar risk 
of developing IBD to non-immigrant children, suggesting that early life or even in utero 
exposures to specific westernized lifestyle may have an influence 129. 
3.1 ENVIRONMENTAL POLLUTANTS 
Among environmental triggers, pollutants are considered a risk factor in IBD pathogenesis. 
As a consequence of human activity, pollutants have a wide distribution and can have an 
impact on entire populations, rather than at the individual level. Thus, understanding how 
they modulate immune responses is imperative. 
Components of air pollution, associated with industrialization and urbanization, have been 
suggested to have detrimental health effects. Regarding the gastrointestinal tract, short-term 
exposure to ingested particulate matter increased intestinal permeability and enhanced the 
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expression of pro-inflammatory cytokines in mice, while long-term exposure also resulted in 
changes in microbiota composition 130. 
However, epidemiological studies assessing the effect of air pollution in IBD have yielded 
conflicting results. Individuals younger than 25 years of age were more commonly diagnosed 
with CD and UC in areas with high levels of NO2 and SO2, respectively 131. Conversely, 
another study reported an inverse association between IBD and particulate matter but a 
positive association with nearby traffic intensity 132. Finally, a study on the number of adult 
IBD hospitalizations found an association between IBD-related hospitalizations and total air 
pollutant emissions as well as with its individual components 133. Overall, future research is 
required to understand if there is a link between elements of air pollution and intestinal 
inflammation and to examine the underlying mechanism. 
3.1.1 Per- and polyfluoroalkyl substances (PFAS) 
In addition to molecules present in the air, we are continuously exposed to other classes of 
anthropogenic compounds. Among these, PFAS are a class of man-made compounds that 
have been vastly used in the production of a large variety of consumer goods, including 
firefighting foams, water repellent textiles, cookware and food packaging 134. PFAS are 
defined as aliphatic substances where all the hydrogen atoms bound to at least one carbon 
atom have been replaced by fluorine atoms 135. Due to the nature of the strong carbon-
fluorine bonds, these compounds are highly persistent, have a global distribution and are 
found in the environment as a result of either their direct emission or degradation of precursor 
substances 135,136. 
PFAS are resistant to metabolic degradation following their absorption 137,138 and their 
bioaccumulative potential increases with the length of the carbon chain 139. PFAS are also 
known as ‘Forever Chemicals’ since their mean half-life in serum in humans has been 
estimated to be 4.8 and 3.5 years for perfluorooctane sulfonic acid (PFOS) and 
perfluorooctanoic acid (PFOA), respectively, both with eight C atoms and the most widely 
characterized compounds from this family 139,140. Considering this, in addition to the adverse 
health effects associated to their exposure (discussed below), PFOA and PFOS have been 
categorized as persistent organic pollutants (POP) in the Stockholm Convention 141. Thus, 
their production and use has been restricted or eliminated in the Western world, although it is 
still produced in other regions, such as in China, due to the lack of cost-efficient alternatives 
142. 
As the production of PFOS and PFOA has been vastly reduced they have been replaced by 
other PFAS with smaller carbon chains, which are deemed less bioaccumulative 139. 
However, a larger amount of the shorter chain PFAS might have to be used to achieve the 
same function performed by the longer chain compounds. Additionally, they can also be 
generated as byproducts of the longer chain pollutants and are widely distributed as a 
consequence. Thus, the general population might be exposed to higher levels of the smaller 
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Figure 3. Overview of the pathways of PFAS exposure in the general population. Adapted from 
Sunderland et al., (2019) 2. 
chain compounds than those of the longer chain PFAS. This represents a concern, since their 
potentially hazardous effects have not been examined in detail.  
Regarding the route of exposure, PFAS have been detected in drinking water sources and in 
wildlife animals 143,144, dietary intake being the primary route of exposure in humans (Figure 
3) 2,145. Following oral exposure, PFAS are well absorbed in the gastrointestinal tract, 
distribute mostly to the liver, blood, kidney and spleen and remain in these tissues 138,146,147.  
Additionally, transporter proteins might help in the absorption of PFAS. PFOA and PFOS 
can be transported by organic anion transporters (OATs) and organic anion transporting 
polypeptides (OATPs), which are highly expressed in the kidney 148-150. Moreover, 
perfluoroalkyl sulfonates, such as PFOS, have been shown to be transported by the apical 
sodium-dependent bile salt transporter (ASBT), which is expressed in the gastrointestinal 
tract, suggesting that they could be preferentially taken up in this manner 151. However, this 
might not be the only route of uptake, as the authors suggest that passive diffusion of PFOS 
might also have an important role 151. 
The interaction of PFAS with proteins in tissues and in the circulation might also help in their 
distribution and bioaccumulation, as more than 90% of PFOA in blood is bound to serum 
albumin in rats and humans 152 and PFOA also binds fatty acid binding proteins 153. Although 
they persist for a shorter period in other species, its half-life in serum is still counted in 
months in rats, mice and monkeys 154. These differences in species-specific pharmacokinetics 









3.1.2 Physiological effects of PFAS exposure 
Several epidemiological studies have been carried out both in the general and in highly 
exposed populations to assess the adverse effects of PFAS exposure in humans. Among these 
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studies, the C8 Health Project is a survey performed in 69,000 residents in districts of Ohio 
and West Virginia, where the drinking water had been contaminated with supplies with 
PFOA. This was attributed to originate from a DuPont plant in the vicinity that manufactured 
PFOA 155. Increased levels of PFAS in serum were positively associated with serum lipids 156, 
kidney disease 157 and pregnancy-induced hypertension 158. Interestingly, results also 
stemming from the C8 Health Project have identified a probable positive association between 
PFOA exposure and testicular and kidney cancers 159, while an inverse association has been 
found for colorectal cancer 160. However, these results should be carefully considered as the 
number of cases in these cohorts remain small and they could be due to chance. Moreover, 
studies performed on workers exposed to higher PFOS levels have suggested an increased 
risk of bladder cancer 160,161. Finally, another study in a small European cohort of exposed 
workers identified a positive association between PFOA serum concentrations and mortality 
of liver cancers, diabetes as well as malignant neoplasms of both hematopoietic and 
lymphatic tissues 162. Overall, a wide variety of health adverse effects following PFAS 
exposure have been identified, although the underlying mechanism is still unknown. 
3.1.3 Effect of PFAS exposure in immune responses 
PFAS exposure from early in life has also been shown to impact the immune system function. 
For instance, epidemiological studies have reported reduced efficacy of vaccines associated 
with PFOS exposure, as serum antibody concentrations were inversely associated with PFOS 
levels in maternal pregnancy serum and in serum in children, which can increase the risk of 
infections 163,164.    
Regarding autoimmune diseases, epidemiological studies have yielded conflicting results in 
terms of association between PFAS exposure and disease incidence. Analysis of the relation 
between PFAS and autoimmune diseases in a highly exposed population, identified a positive 
association between PFOA serum levels and the incidence of ulcerative colitis but not 
Crohn’s disease 165. This association was also found in a second cohort where the mean PFAS 
serum levels were comparable to those in the general US population 166. However, a more 
recent study performed in a community with high exposure to PFAS in Sweden examined 
serum PFAS levels and IBD biomarkers levels, but it did not find an association between 
PFAS exposure and IBD 167. Differences between cohorts, e.g. the duration of the exposure to 
PFAS and other environmental factors, as well as in the study design, might affect the 
interpretation of the results. Therefore, further studies in other populations examining 
additional biomarkers in samples collected before and after the diagnosis of IBD might help 
to better understand if there is a causal link, and what could be the potential mechanisms 
resulting in intestinal inflammation. 
Studies in other mammalian models have shed more light on the impact of PFAS exposure on 
the immune system. Regarding the innate immune system, short-term exposure to PFOA 
leads to neutropenia, in addition to a general reduction in circulating white blood cells and 
lymphocytes in mice. Moreover, exposure to PFOA in vivo prior to stimulation with LPS 
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leads to increased ex vivo production of proinflammatory cytokines, such as TNF-a and IL-6, 
in cells isolated from the peritoneal cavity or the bone marrow 168.  
Adaptive immunity is also affected by PFAS. In utero exposure to PFOS resulted in reduced 
specific IgM titers following immunization during adulthood, as well as in reduced NK cell 
activity in mice 169. Exposure to PFOS in adult mice also led to reduced antigen-specific IgM 
production following immunization and in alterations in T cell subpopulations in male mice, 
which showed a 14-fold lower low observed adverse effect level (LOAEL) value than 
females 170. Short-term high exposure to PFOS or PFOA through diet resulted in atrophy of 
the thymus and spleen in mice, while it also led to a reduction in the number of myeloid cells 
and lymphocytes in the bone marrow 171.  
In terms of the immune responses elicited by PFAS, a long-term exposure to PFOS resulted 
in a shift towards a higher IL-4 production, characteristic of a type 2 cytokine response, and 
increased antibody titers against a specific antigen following immunization 172. Specifically in 
the intestine, Wang et al. (2020) have shown that a PFOS administration in mice for 16 days 
causes increased expression of Il1b and Il10 in the colon, while also reducing the expression 
of tight junction proteins and affecting intestinal permeability. This was also accompanied by 
inflammatory responses and oxidative damage in the liver 173. Moreover, while PFOS 
administration prior to Citrobacter rodentium infection in mice, a widely used model to study 
enteropathogenic infections 174, resulted in enhanced pathogen clearance at early stages, 
continuous PFOS exposure led to chronic inflammation during later stages of infection. In 
addition, this was associated with decreased mucin production by goblet cells and changes in 
the microbiota composition at later stages of infection 175. In this study, PFOS promoted the 
production of type 3 cytokines such as IL-17 and IL-22 by ILC3s and TH17 cells through 
activation of the aryl hydrocarbon receptor (AHR) 175. However, its effect on myeloid cells, 
and on early stages of intestinal inflammation remains vastly unclear. In the last manuscript 
included in this thesis we expanded on this concept and showed that PFOS exposure upon 
chemically induced colitis resulted in exacerbated intestinal inflammation and epithelial 
permeability, associated with increased PFOS bioavailability systemically. 
3.2 EFFECT OF DIETARY-DERIVED COMPOUNDS IN IBD. 
Among the environmental factors that have been associated to play a role in IBD 
pathogenesis, diet is believed to play a crucial role. Particularly, dietary modifications have 
been shown to induce dysbiosis in mice, a risk factor in the development of IBD. For 
instance, mice whose diet changed from a low-fat and plant polysaccharide-rich to a high-fat 
and high-sugar diet, characteristic of a Western diet, showed rapid changes in the structure of 
the microbiota 176, as well as increased intestinal permeability and decreased barrier function 
177. Another study showed that a high-fat and high-sugar diet induced an inflammatory 
environment in the gastrointestinal tract and facilitated colonization by pathogenic bacteria, 
which was associated with an exacerbated colitis 178. 
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In a prospective study in humans, increased energy intake from polyunsaturated fatty acids 
(PUFA) has shown a marginally significant positive association with ulcerative colitis 
incidence 179. Particularly, high consumption of linoleic acid, an omega-6 (n-6) PUFA present 
in red meat and cooking oils, has been positively associated with UC incidence 180. 
Conversely, greater long-term intake of n-3 PUFA was associated with a trend of lower UC 
incidence and the ratio of n-3:n-6 intake inversely associated with disease risk, suggesting a 
protective effect of the n-3 PUFA 181. Regarding other macronutrients, significant association 
between UC or CD incidence and the intake of carbohydrates, protein or total energy intake 
has not been detected 179,182. 
Besides high-fat and high-sugar, a Western diet is also characterized by high intake of red 
meat, refined grains and processed food, instead of fruits and vegetables, which are rich in 
fiber 183. Vegetable consumption and fiber intake were inversely associated with fecal 
calprotectin levels, a marker of gastrointestinal inflammation 184. Furthermore, women and 
children that consumed higher levels of dietary fiber had a reduced risk of developing CD but 
not UC, with fruit and vegetables being the sources that showed a significant association 
185,186. Although dietary fiber is nondigestible, its protective effects can be partially explained 
by products of its fermentation by the intestinal microbiota, such as short-chain fatty acids 
(SCFAs) 187. SCFAs have anti-inflammatory properties, by supporting the generation of Treg 
and increasing tolerogenic dendritic cells 188,189, while also promoting the epithelial barrier 
function by enhancing the assembly of tight junctions 190. 
In addition to macronutrients, vitamins and minerals might also play an important role in IBD 
pathogenesis. For instance, administration of vitamin D in mice undergoing chemically 
induced colitis led to a milder disease course 191 and a prospective study showed an inverse 
association between plasma levels of vitamin D and CD incidence in women 192. 
Additionally, micronutrients can act as co-factors of enzymes involved in maintaining the 
epithelial barrier function. For example, prospective studies have found that higher zinc 
intake was associated with a reduced risk of developing CD but not UC 193, while its 
supplementation can reduce intestinal permeability in patients with Crohn’s disease in 
remission 194. 
Taken together, dietary composition has a major role in shaping immune homeostasis and in 
maintaining intestinal barrier function in the gastrointestinal tract. 
3.2.1 Ligand-activated transcription factors in intestinal homeostasis 
Dietary-derived metabolites and xenobiotics can activate ligand-activated transcription 
factors, hence regulating gene expression directly. Micro- and macronutrients, such as fatty 
acids, sterols, bile acids, retinoids and vitamins, can be sensed by these transcription factors 
195. Although the expression of these sensors varies between cell types, they are usually 
expressed by immune and intestinal epithelial cells. 
Among the ligand-activated transcription factors, members of the nuclear receptors (NR) 
sense and translate the environmental cues to gene expression rapidly compared to cell 
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surface receptors. Among the NRs, some (e.g. AR, ER) are present in the cytoplasm and 
translocate to the nucleus upon ligand binding. On the other hand, other NRs (e.g. LXR, 
RAR) are located in the nucleus, bound to DNA on a basal state, inhibiting gene transcription 
195. Upon ligand-dependent activation co-activators are recruited, which leads to gene 
transcription. Particularly, the liver X receptor (LXR) and the retinoic acid receptor (RAR) 
are nonsteroid nuclear receptors that bind to DNA response elements as part of a heterodimer 
with the retinoic X receptor (RXR) 196,197. Additionally, AHR, which is a ligand-activated 
transcription factors but does not fit the strict criteria of NR, is located in the cytoplasm and 
translocates to the nucleus upon ligand-dependent activation, where it binds the AHR nuclear 
translocator (ARNT) and is recruited to AHR-responsive DNA elements 198.   
Metabolites of the amino acid tryptophan as well as those derived from cruciferous 
vegetables, such as indoles, and xenobiotics can be sensed by AHR 198. Its activation 
regulates the differentiation of Treg and TH17 cells in a ligand-dependent fashion 199, as well 
as the production of cytokines, such as IL-17 and IL-22 200. AHR is also required for the 
maintenance and function of intestinal RAR-related orphan receptor (ROR)gt+ ILCs and the 
control of Citrobacter rodentium infection 201, whose clearance is dependent on IL-22 
production. Additionally, AHR is essential for the expansion of RORgt+ lymphoid tissue 
inducer (LTi) ILCs, and its deficiency results in an absence of cryptopatches, and isolated 
lymphoid follicles 202. Finally, AHR is also required for the differentiation of intestinal stem 
cells and helps to maintain barrier homeostasis 203. 
LXR is activated by cholesterol-derived metabolites called oxysterols and has a key role in 
the regulation of cholesterol metabolism 196. LXR also controls inflammatory responses, 
inhibiting the expression of proinflammatory mediators induced by LPS in macrophages and 
suppressing TH17 differentiation in mice 204,205. In addition, LXR deficiency in mice leads to 
increased susceptibility to colitis and exacerbated disease in the experimental autoimmune 
encephalomyelitis (EAE) model of multiple sclerosis 205,206. Moreover, a recent study from 
our lab has shown that LXR controls the expansion of TH17 and RORgt+ Treg in the intestine 
draining lymph node MLN 207, suggesting LXR mediated regulation of T cells might play a 
critical role in intestinal inflammation.  
Retinoids and metabolites of vitamin A can activate RARs (-a, -b and -g), which have a 
broad impact on the immune system development. For instance, supplementation of vitamin 
A in the diet of pregnant mice results in increased numbers of RORgt+ LTi ILCs in the 
embryo, while mice fed with a vitamin A deficient diet through life had secondary lymphoid 
organs with a reduced size 208. Additionally, retinoic acid regulates the development of 
intestinal DC subsets, promoting the generation of anti-inflammatory Foxp3+ Treg in the MLN 
while inhibiting the differentiation towards proinflammatory TH17 cells 209-212. This is 
particularly important in the GI tract, where balancing the ability to mount an immune 
response against pathogens while keeping tolerance to food antigens is crucial to maintain 
homeostasis. Lastly, RA is necessary for the induction of gut homing receptors in T and B 
cells, and for the presence of IgA-producing B cells in the intestine 213,214.  
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Dietary retinoids can be absorbed and metabolized by IECs in the small intestine 215, although 
its impact on these cells remains largely unexplored. Recently, we and others have shown that 
lack of RARa signaling in IECs led to an altered epithelial composition of secretory cells, 
with increased numbers of goblet and Paneth cells and a reduction in the number of 
enteroendocrine cells in the small intestine 1. Deletion of RARa signaling in IECs also 
impacted the development of the intestinal immune system, evidenced by a decrease in the 
number of mononuclear phagocytes and in the number of isolated lymphoid follicles 1. 
Additionally, lack of epithelial RARa conferred increased susceptibility to infection in both 
the small and large intestine, to both Salmonella Typhimurium and Citrobacter rodentium, 
respectively 1,216.  
Finally, analysis of the role of signaling of another RAR isoform in the epithelium, in this 
case RARb, revealed that it is essential for the production of serum amyloid A (SAA) 
proteins, and in turn, modulating the production of IL-17 by TH17 cells 217. In sum, RAR 
signaling is crucial for the development and function of intestinal immunity. 
Taken together, dietary-derived metabolites can be sensed by ligand-activated transcription 
factors and regulate immune homeostasis by modulating gene expression. Although their 
impact in immune responses has been widely studied individually, the effect of simultaneous 
receptor activation is unknown. Recently, we have addressed the effect of combinatorial 
receptor activation and found that this can lead to synergistic or antagonistic modulation of 





Figure 4. Zebrafish are relevant models for in vivo phenotypical screenings. Around 71% of human genes 
have an ortholog in zebrafish.  Zebrafish possess vertebrate organ systems and share a high degree of genetic 
of physiology with humans, e.g. in cardiac electrophysiology. Zebrafish larvae can be grown in 96 or 384-
well plates, offering the potential of high-throughput screenings. Different readouts based on image analysis 
using fluorescent reporter lines, in situ hybridization or potentially transcriptomics can be analyzed. Positive 
hits can be identified and validated in mammalian in vivo models. Adapted and modified from MacRae and 
Peterson, (2015) 5, and Diaz et al., (2019) 6. 
4 ZEBRAFISH AS A RESEARCH MODEL FOR IBD 
 
As indicated above, environmental triggers have a major role in modulating intestinal 
immune responses. Nonetheless, examining the effect of the thousands of compounds that we 
are continually exposed to requires a model that allows the testing in a high-throughput 
manner. 
Phenotypic-based screenings performed in cultured cells allow the screening of compounds at 
high-throughput and analyzing cell-autonomous processes. However, intestinal homeostasis 
is maintained by a complex network of cell types. Hence, a model to test the impact of 
environmental triggers in intestinal inflammation should recapitulate the complexity of these 
biological processes in vivo. A vertebrate model that has recently been used in screenings is 
zebrafish. Assays are often performed in zebrafish larvae, which are optically transparent and 
allow the imaging of internal organs in an intact organism 5. Zebrafish have become a 
relevant model for screenings in drug discovery, considering several advantages in 
comparison to other vertebrates such as: i) high fecundity, with females laying ~300 embryos 
per cross; ii) small size in early developmental stages, making it possible to grow embryos in 
96- or 384-well plates; iii) external fertilization, allowing an easier genetic modification; iv) 
reduced cost of husbandry. Additionally, fish can be exposed to many drugs by immersion, 
which presents an easier administration route compared to those used in other vertebrate 
models 6 (Figure 4).  
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Conservation of genetics and physiology between zebrafish and humans further support the 
use of this model in drug screening. The zebrafish genome has been fully sequenced, and 
zebrafish orthologues have been identified for 71% of human genes, which increases to 82% 
when considering disease-causing genes 218. In terms of physiology, zebrafish contain organ 
systems found in mammals. Additionally, major biological processes are conserved, which 
can have a higher similarity to that in humans than rodents, such as the case of the cardiac 
electrophysiology 5. Finally, although few compounds that have been identified in zebrafish 
have been tested in humans, drugs with known function in humans show high conservation of 
their pharmacological effect in zebrafish 219. 
To date, more than 65 screens have been performed in zebrafish, with several disease-
relevant compounds having been identified and tested in preclinical models and/or clinical 
trials. Interestingly, these screens have not only identified new compounds, but also have 
been useful for identifying novel uses for existing drugs that have already been approved for 
clinical use 5. For example, dimethyl prostaglandin E2 (dmPGE2) was found to increase 
hematopoietic stem cell numbers in a screening performed in zebrafish larvae 220 and 
expanded hematopoietic stem cell numbers in umbilical cord blood units prior to 
transplantation in a Phase I clinical trial 221. In sum, this highlights the use of zebrafish as a 
relevant model to identify novel compounds with potential therapeutic use. 
4.1 THE GI TRACT IN ZEBRAFISH 
In contrast to mammals, zebrafish are stomach-less, and the esophagus is directly connected 
to the intestine, which is a folded tube located in the abdominal cavity 222. Considering 
histological features and the presence of different epithelial cell types, the intestine can be 
divided in three segments. The anterior segment, referred to as the intestinal bulb, has a wider 
caliber and greater epithelial surface than the posterior intestine. This segment also expresses 
high levels of digestive enzymes, which is in agreement with its primary role being nutrient 
absorption. Enteroendocrine cells are absent in the middle segment, where enterocytes 
express digestive enzymes, suggesting also an involvement in nutrient absorption. The 
terminal segment is devoid of enterocytes and the epithelial folds are short, which resembles 
the colon of mammalian vertebrates 222. Gene expression and transcriptional regulatory 
mechanisms are highly conserved along the intestine from zebrafish to mammals, suggesting 
the conservation of the function of IECs 223. 
However, there are some differences between the zebrafish intestine and that of mammals, in 
terms of the epithelial architecture and the cell types present. For instance, the epithelial wall 
is characterized by large epithelial folds, which are, in proportion, larger than those of 
mammals. Moreover, proliferating cells in the zebrafish intestine and those expressing the 
stem cell marker olfm4 are only located at the base of the epithelial folds, analogous to their 
location in mammals, although not in crypts, as the typical mammalian crypt-villi architecture 
is absent 224,225. The mucosal layer is directly surrounded by the smooth muscle layer in 
zebrafish, while in mammals an intermediate layer, the submucosa, contains a thick layer of 
connective tissue embedding blood vessels, lymphatics and enteric nerves 222,223. Till date, 
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only three intestinal epithelial cell types have been identified in zebrafish, including 
enterocytes, enteroendocrine and goblet cells, while M cells, tuft cells and Paneth cells are 
absent 224. Finally, although the zebrafish lymphatic system shows similarities to those in 
higher vertebrates, some structures, such as Peyer’s patches and lymph nodes, are absent 
(Figure 5) 226,227.  
During embryogenesis, the zebrafish intestine develops into a functional structure able to 
absorb nutrients by the end of this stage, although it does not fully mature into the adult 
pattern of epithelial cell proliferation and replacement until 4 weeks later. During the first two 
weeks post embryogenesis, cells proliferate at the base of the epithelial folds, migrate up 
during the third week and finally reach the tip fold, where they undergo apoptosis, by the end 
of the fourth week 222,228. Moreover, the formation and differentiation of the zebrafish 
intestinal epithelium is affected by the microbiota, as its presence increases not only the 
proliferation of epithelial cells but also their differentiation towards goblet and 
enteroendocrine cells 229,230. Zebrafish represent an attractive animal model for studying host-
pathogen interactions, since they develop in germ-free conditions protected by their chorion 
and the colonization of the gut by the microbiota takes place after hatching, allowing for a 















Figure 5. Comparison of the intestine of zebrafish and mouse. The epithelial lining of mouse and zebrafish 
contain absorptive enterocytes, stem cells, goblet cells and enteroendocrine cells. However, Paneth cells, M cells 
and tuft cells have only been reported in mice. The architecture of crypt-villus present in mice is not present in 
zebrafish, where stem cells are located at the bottom of invaginations. Moreover, lymphoid structures, such as 
lymph nodes and Peyer’s patches are absent in zebrafish. Finally, the submucosal layer, located between the 
lamina propria and the muscle layer is also absent in zebrafish. Adapted and modified from (Diaz et al., 2019) 6. 
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4.2 THE ZEBRAFISH IMMUNE SYSTEM 
The zebrafish immune compartment contains most of the immune cells already described in 
vertebrates. Innate immune cells are among the first cells to appear during development, with 
macrophages being observed as early as 24 hours post fertilization (hpf) 232 while 
granulocytes have been identified at 48 hpf 233,234. Cells belonging to the dendritic cell lineage 
in zebrafish have phagocytic capacity and are involved in antigen presentation while also 
having the classic morphology of their mammalian counterparts 235. Mast cells have also been 
observed in mucosal tissues in zebrafish larvae, similar to their location in mammals 236, 
while eosinophils have been observed in adult fish 233. Innate lymphocytes, including NK and 
cells resembling ILCs, have also been recently described in the gastrointestinal tract of adult 
zebrafish 237,238. 
Adaptive immunity is also present in zebrafish. As in mammals, T cell lymphopoiesis takes 
place in the thymus, and the presumptive thymic rudiment has been identified as early as 48 
hpf 239, while it is first colonized by immature lymphoblasts at 65 hpf 240. The expression of 
rag1 and rag2, genes involved in the arrangement of the B and T cell receptors, was first 
observed in the thymus at 92 hpf, which continues to enlarge and acquires its mature structure 
at 1 month 241, suggesting that a fully functional T cell immunity is not present in larval 
stages. However, a recent study has shown that there are 2 waves of lymphopoiesis in 
zebrafish: a transient wave, where only CD4 ab T cells are generated, lasts until late juvenile 
stages and is HSC-independent; and a late definitive wave, that takes place from larval stages 
to adulthood and gives rise to all types of T cells, derived from HSCs 242. Additionally, gd T 
cells have also been identified in zebrafish, being primarily located in mucosal tissues, such 
as the skin, gills and intestine and promoting humoral immunity 243. 
The generation of a cd4 transgenic reporter in zebrafish has allowed the visualization of the 
development and characterization of CD4+ T cells in this model. Treg-like cells in zebrafish 
are enriched in the gut mucosa in zebrafish, similar to mammals, have a gene expression 
signature similar to those in mammals and its absence leads to chronic inflammation, 
indicating that they also possess immunosuppressive activity 244,245. Cells showing increased 
expression of gata3 and il4/il13b, characteristic of mammalian TH2 cells, were enriched in 
the gills and the absence of both il4/il13a and il4/il13b leads to a proinflammatory state in 
zebrafish and to an imbalance towards type 1 immune responses 244,246. However, if TH1 and 
TH17 cells exist in teleost fish and if their function is fully conserved compared to the 
mammalian counterparts remains to be investigated. 
Humoral immune responses, the other arm of adaptive immunity, are also conserved in 
teleost fish. B cells have been identified at 20 days post fertilization between the dorsal aorta 
and posterior cardinal vein and in the kidney of zebrafish, while also found in spleen, liver, 
gills and gut in adults 247. Three types of immunoglobulins have been described: IgD, IgM, as 
in mammals, and IgZ/T, which seems to be the functional equivalent of the mammalian IgA, 
as it is more abundant in the gut mucosa coating luminal bacteria 248-250. 
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4.3 STUDYING INTESTINAL INFLAMMATION IN ZEBRAFISH 
In view on the high degree of genetic and physiologic conservation between zebrafish and 
mammals and their advantages over other systems described above, it has emerged as a 
suitable in vivo model to study immune responses to a wide variety of environmental 
compounds in a cost-effective manner. Regarding intestinal immunity, inflammation in the 
gastrointestinal tract can be driven in zebrafish by exposure to chemicals 251,252, dietary 
compounds 253,254 and in genetic models 255,256.  
Chemically induced models can be used at different developmental stages and do not require 
genetic manipulation. Additionally, drugs and chemicals that drive inflammation can be 
dissolved in the aqueous media of the zebrafish larvae, thus greatly facilitating their 
administration, which is essential for increasing the throughput of drug screenings. Finally, 
chemically induced models of intestinal inflammation in zebrafish larvae were recently 
utilized in a screening to test well-characterized drugs and identified novel hits that alleviate 
intestinal neutrophilic inflammation 257. Altogether, this underlines the use of zebrafish as an 






5 AIMS OF THE THESIS 
The general aim of this thesis was to investigate the contribution of environmental factors and 
genetics in the initiation of intestinal inflammation. 
In particular, the specific aims of each study were as follows: 
Study I: To characterize how retinoic acid receptor a signaling in intestinal epithelial cells 
affects intestinal immune homeostasis. 
Study II: To examine the cytokine profile induced by combinatorial activation of dietary 
sensors, such as ligand-activated transcription factors. 
Study III: To study the mechanisms by which GPR35 signaling mediates intestinal immune 
homeostasis. 
Study IV: To investigate the immunomodulatory effects of per- and polyfluoroalkyl 






6 MATERIALS AND METHODS 
This section briefly describes the main materials and methods used in the four manuscripts 
included in this thesis. For more details, please refer to the materials and methods section of 
each manuscript.  
6.1 ANIMAL STUDIES (STUDY I-IV) 
All mice experiments were approved by the Stockholm regional ethics committee, the 
Massachusetts General Hospital (Boston, USA) and following the Swiss Federal and 
Cantonal regulations (Switzerland). All mice were used between 6 and 12 weeks of age, 
maintained under specific pathogen-free conditions and handled according to guidelines and 
regulations established by institutional, regional and national authorities. 
Zebrafish embryos were obtained from natural spawning of adult zebrafish housed under 
ethical permits approved by the Stockholm regional ethics committee. Larvae were raised at 
28°C and experiments were terminated between 96 and 120 hours post fertilization, a 
developmental stage at which larvae are not yet considered animals according to European 
regulations. 
Reference numbers for all ethical permits are indicated in each manuscript. 
6.2 HUMAN SAMPLES (STUDY III) 
The patient samples were collected and stored following the regulations of the Ethics 
Committee for Northwest and Central Switzerland. 
6.3 INTESTINAL INJURY MICE MODELS (STUDY I, III AND IV) 
Several models of intestinal inflammation were used in the studies included in this thesis. 
In study I, Citrobacter rodentium infection was performed using a bioluminescent strain of 
this bacteria. Sex-matched mice were inoculated by oral gavage with 2 x 109 colony-forming 
units (CFU) resuspended in PBS. Mice were sacrificed on day 14 post infection. 
In study III, colitis was induced by administration of 1.5-2.5% (w/v) dextran sulfate sodium 
(DSS, MP Biomedicals) in the drinking water ad libitum for 5 days, followed by 2 days of 
regular water to allow tissue repair. 
In study III, mice were challenged with an E.coli strain expressing ovalbumin (OVA). Mice 
were orally gavaged every other day for 21 days with 108 CFU and sacrificed at this 
timepoint. 
In study IV, colitis was chemically induced with 2,4,6-trinitro benzene sulfonic acid (TNBS, 
Sigma-Aldrich). TNBS diluted in in H2O was mixed in a 1:1 ratio with absolute ethanol, for 
a final TNBS concentration of 1-2.5%, and administered intrarectally under anesthesia using 
a plastic feeding needle. Mice were analyzed 1-6 days after colitis induction. 
 
26 
6.4 ANTIBIOTIC TREATMENT OF MICE (STUDY III) 
Mice were given an antibiotic cocktail containing Ampicillin, Kanamycin, Gentamicin, 
Metronidazole, Neomycin and Vancomycin by oral gavage for 10 consecutive days. 
6.5 PROCESSING OF TISSUES (STUDY I, III AND IV) 
For obtaining single cell suspensions from the colon and small intestine, the intestines were 
harvested and placed in PBS or Hank’s balanced salt solution (HBSS) on ice. Following 
removal of the mesenteric fat, the segments were opened longitudinally, washed and cut into 
1 cm pieces. Dissociation of IECs was performed by incubation at 37°C in 5 mM EDTA and 
1mM DTT in buffered solutions under agitation. To analyze the epithelial fraction (Study I), 
the supernatant was collected, filtered through a 70 µm cell strainer and centrifuged at 500 g, 
with the pellet containing IECs. To obtain cells from the lamina propria, the tissue pieces 
were washed and digested in HBSS or RPMI medium containing 0.1 mg/ml DNase I (Roche) 
and 0.15 mg/ml Liberase TL (Roche) or 0.5 mg/ml Collagenase type VIII (Sigma-Aldrich) 
under agitation at 37°C. Cells were then washed, filtered through a 70 µm cell strainer and 
leukocytes were enriched through Percoll gradient (Studies I and IV). 
Cell suspensions from the spleen were obtained by mashing the tissues with a syringe plunger 
through a 70 µm cell strainer. 
6.6 FLOW CYTOMETRY AND FLUORESCENT ACTIVATED CELL SORTING 
(STUDY I, III AND IV) 
Single cell suspensions were incubated with anti-CD16/CD32 antibodies (eBioscience) to 
block non-specific binding and Fixable Viability Dye (eBioscience) at 4°C for 15 min. Cells 
were then stained at 4°C for 15 minutes with different cocktails of fluorescently labeled 
antibodies for surface antigens. For intracellular staining, cells were then fixed and 
permeabilized with fixation and permeabilization buffers (Foxp3 Transcription Factor 
Staining Buffer Set, eBioscience or Fixation/Permeabilization Solution Kit, BD Biosciences) 
followed by staining at RT for 20 minutes with fluorescently labeled antibodies against 
intracellular antigens. Samples were then acquired using FACS Canto II and FACS LSR 
Fortessa flow cytometers (BD Biosciences). Analysis was performed with FlowJo software 
(TreeStar). 
6.7 HISTOLOGY AND HISTOLOGICAL SCORING (STUDY III AND IV) 
Tissue pieces from the colon were collected, fixed in 4% paraformaldehyde (PFA) and 
embedded in paraffin. Sections were stained with H&E and assessed semi-quantitatively by 
blind investigators or pathologists following established criteria for the corresponding 
models. 
6.8 IMMUNOSTAINING (STUDY I AND III) 
Immunohistochemistry: Mouse tissues were fixed in 4% PFA dehydrated in ethanol solutions 
and embedded in paraffin. Tissues were sectioned at 4-6 µm, de-waxed and rehydrated before 
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heat-mediated antigen retrieval in citrate buffer or EDTA buffer. Endogenous peroxidase was 
blocked with BLOXALL Blocking solution (Vector Laboratories). Sections were stained 
with primary antibodies followed with corresponding secondary antibodies. Additionally, all 
samples were counterstained with hematoxylin and eosin prior to mounting. For goblet cell 
staining, slides were incubated in a solution containing 1% Alcian Blue in 3% acetic acid for 
5 minutes and counterstained with Nuclear Fast Red solution. Images were quantified in a 
blind fashion using the ImageJ software. For the analysis of whole small intestines and 
colons, tissues were prepared as Swiss rolls, placed in cassettes containing OCT compound, 
and submerged in isopentane cooled with liquid nitrogen. Samples were stored at -80°C until 
sectioning in 5 µm sections and stained using primary and corresponding secondary 
antibodies. 
Immunofluorescence: Following fixation and dehydration, tissues were embedded in paraffin 
or prepared for cryo-embedding. Human biopsies were provided in cryoblocks. Six 
micrometer sections were fixed in PFA and blocked and permeabilized with PBS containing 
0.4% Triton X-100 or 0.1% Tween20, and 5% goat serum. Sections were stained with 
primary and secondary antibodies and a nuclear staining and imaged with a Nikon A1R 
confocal microscope. 
6.9 FLUORESCENCE IN SITU HYBRIDIZATION (STUDY I) 
Tissues from the distal ileum were prepared for fixation in Carnoy’s fixative, embedded in 
paraffin and sectioned at 5 µm. Sections were hybridized to a bacterial universal probe 
against the 16s rRNA gene, conjugated to Alexa488. DAPI was used as a counterstain and 
tissues were visualized using a CHGR Leika SP5 microscope. Images were taken at 10x 
magnification and analyzed automatically using the CellProfiler software. 
6.10 EXPOSURE TO METABOLITES, POLLUTANTS, ANTIBIOTICS AND TNBS 
IN ZEBRAFISH LARVAE (STUDY I-IV) 
In studies I and II, zebrafish larvae were exposed by immersion to ligands of AHR (FICZ, 
100 nM, Syntastic), RAR (retinoic acid, 1 µM, Sigma-Aldrich) and LXR (GW3965, 1 µM, 
Sigma-Aldrich) from 72 to 108 hpf. All ligands were dissolved in E3 water and renewed 
every 24 hours. 
In study III, zebrafish larvae were stimulated with 10 µM lysophosphatidic acid (LPA; 
Sigma-Aldrich) or 10 µM Zaprinast by immersion in E3 water from 96 to 120 hpf. 
In study III, zebrafish larvae were exposed by immersion from 72 to 120 hours post 
fertilization (hpf) to an antibiotic cocktail consisting of Ampicillin and Kanamycin. 
Antibiotics were dissolved in E3 water and the media was replaced every 24 hours. 
In studies III and IV, zebrafish larvae were exposed to 50 or 70 µg/ml TNBS (Sigma-
Aldrich) from 72 to 120 hpf. TNBS was dissolved in E3 water and replaced every 24 hours. 
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6.11 INJECTIONS OF LPA AND VIBRIO ANGUILLARUM IN ZEBRAFISH 
LARVAE (STUDY III) 
A formaldehyde-inactivated extract of V. anguillarum was mixed in a 1:1 ratio with phenol 
red (Sigma-Aldrich) and diluted 1:3 with PBS. Two nL of this mixture were injected in the 
swim bladder and intestinal region of 110 hpf anesthetized zebrafish larvae with 0.016% 
Tricaine MS-222 (Sigma-Aldrich). Larvae were monitored until recovered and analyzed 6 
hours after the injection. 
Two nL of a mixture of LPA (10 µM) and FITC-Dextran (500 µg/ml) in PBS was injected in 
the otic vesicle of 110 hpf anesthetized larvae. Larvae were monitored for recovery and 
macrophage recruitment was analyzed 6 hours post injection. 
6.12 ZEBRAFISH LIVE IMAGING AND IMAGE ANALYSIS (STUDY III AND IV) 
At the desired timepoint, larvae were washed in E3 medium and anesthetized with 0.016% 
Tricaine MS-222. Larvae were embedded in 1% low melting point agarose (Sigma-Aldrich) 
dissolved in E3 water and positioned in Petri dishes for imaging. Imaging of macrophage 
recruitment was done using a Leica M165FC stereomicroscope (Leica) (study III). 
For study IV, epifluorescence was analyzed using a SMZ25 Research Stereo Microscope 
(Nikon). Images were cropped to include the region of interest and analyzed automatically 
with the software CellProfiler. Confocal images were taken with a Zeiss LSM800 microscope 
and the number of neutrophils recruited to the intestine were manually counted. Light-sheet 
imaging was performed with a Light Sheet Z.1 microscope and 5x air detection objectives. 
6.13 WHOLE-MOUNT IN SITU HYBRIDIZATION (STUDY III) 
A DNA plasmid containing gpr35b cDNA was linearized using restriction enzymes to 
generate the templates for the sense and antisense probes. Sense and antisense digoxygenin 
(DIG)-labeled RNA probes were transcribed using a DIG-RNA labeling mix, RNase inhibitor 
and T7 and T3 RNA polymerase, respectively. The DNA template was digested using DNase 
I and the RNA probes were precipitated and purified using the lithium chloride method. 
In situ hybridization was done in whole zebrafish larvae at 72, 96 and 120 hpf. At the 
corresponding developmental stage, larvae were fixed in paraformaldehyde (PFA) and 
dehydrated in methanol, followed by depigmentation. Larvae were then rehydrated and 
digested with proteinase K for a specific time depending on the developmental stage. The 
reaction was stopped by incubation in PFA, larvae were washed and placed in 
prehybridization mix. Larvae were then incubated in hybridization mix containing the DIG-
labeled RNA probe overnight at 70°C. This was followed by incubation with an anti-DIG 
antibody conjugated to alkaline phosphatase (AP) and the addition of a chromogenic AP 
substrate. When the desired intensity signal was observed, the reaction was stopped by the 




6.14 3´-5´-CYCLIC ADENOSINE MONOPHOSPHATE (CAMP) ASSAY (STUDY 
III) 
The in vitro screening of GPR35 ligands was performed in a Chinese hamster ovary (CHO)-
K1 cell line overexpressing human GPR35 coupled to a G protein that inhibits the 
accumulation of forskolin-induced cyclic AMP (cAMP), as a response to GPR35 agonists. 
Cells were treated with 15 µM forskolin and serial dilutions of potential ligands, including 10 
µM recombinant CXCL17, 10 µM LPA and 10 mM kynurenic acid. Zaprinast was used as a 
positive control. cAMP levels were measured by enzyme-fragment complementation (EFC) 
technology. Two fragments of the b-galactosidase enzyme were used. When free cAMP was 
present, cAMP labeled with one part of the enzyme was outcompeted to bind to an anti-
cAMP antibody, complemented the enzyme complex and cleaved the substrate. This 
produced a luminescent signal that was analyzed with a microplate reader. 
6.15 WHOLE-MOUNT ALCIAN BLUE STAINING IN ZEBRAFISH LARVAE 
(STUDY I) 
Larvae were fixed in PFA, rinsed in acidic ethanol (70% ethanol with 1% hydrochloric acid), 
and incubated in alcian blue staining solution (0.1% alcian blue in 80% ethanol and 20% 
glacial acetic acid) for 3 hours at 4°C. Larvae were repeatedly rinsed with acidic ethanol to 
remove the excess staining and mounted in glycerol for imaging using a Leica M165FC 
stereomicroscope (Leica). Quantification of positive cells from the middle segment of the 
intestine to the anus was done manually in a blind manner. 
6.16 CHEMICAL ANALYSIS (STUDY IV) 
Liver tissues were sectioned and homogenized using a TissueLyser (Qiagen) with a 0.5mm 
stainless steel bead, followed by vigorous shaking at room temperature and centrifugation. 
Liver extracts and serum were diluted in a mixture of acetonitrile/water and transferred to a 
glass insert. The tissue extracts or serum were injected onto the liquid chromatography – 
mass spectrometer (LC-MS). The samples were analyzed in a Shimadzu UFLC system 
(Shimadzu Corporation) coupled to a QTRAP5000 (triple quadrupole linear ion trap mass 
spectrometer) equipped with a TurboIon Spray source (AB Sciex). All samples were 
analyzed in technical duplicates. Excellent linearity was observed for the calibration 
standards. 
6.17 RNA EXTRACTION AND QUANTITATIVE PCR ANALYSIS (STUDY I-IV) 
For analysis of gene expression in cells, mouse or zebrafish tissues, whole zebrafish larvae or 
human biopsies, RNA was extracted using TRI Reagent (Zymo Research), TRIzol LS reagent 
(Invitrogen). Alternatively, mice tissues in study I were collected in RNAlater, homogenized 
and RNA was extracted with the RNeasy kit (Qiagen) according to the manufacturer’s 
protocol. For colonic tissues from DSS-treated mice (Study III), the DSS residues were 
removed with the Direct-zol RNA MiniPrep kit (Zymo Research). RNA samples were treated 
with TURBO DNase (Invitrogen, study III) and reverse-transcribed using the iScript cDNA 
Synthesis kit (Bio-Rad) or High Capacity cDNA Reverse Transcription (Applied 
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Biosystems). Analysis of gene expression was performed by quantitative PCR using 
QuantiNova SYBR Green PCR (Qiagen) or iTaq Universal SYBR Green Supermix (Bio-
Rad) kits and run on an ABI ViiA 7 cycler (Applied Biosystems), CFX384 Touch Real-Time 
PCR (Bio-Rad) or iQ5 Multicolor Real-Time PCR Detection System (Bio-Rad). Relative 
quantities of mRNA transcripts were calculated using the DDCt method and eef1a1l1 
(zebrafish), Hprt, Gapdh or Actb (mouse) as housekeeping genes. 
6.18 RNA SEQUENCING (STUDY III) 
RNA was isolated from sorted colonic GPR35+ or GPR35- macrophages from Gpr35-
tdTomato mice or bone marrow-derived macrophages from WT or Gpr35-/- mice. RNA 
quality and concentration were measured. Indexed cDNA libraries were prepared using 
commercial kits (Illumina), pooled and sequenced using the NovaSeq 6000 instrument or 
NextSeq 500 Sequencing System (Illumina).  
Reads were aligned to the mouse genome (UCSC version mm10) with STAR (version 
2.5.2a). The quality of the reads and alignment was evaluated with the package QuasR in R 
(version 3.4.2). Differential gene expression analysis was performed using the edgeR 
package. Genes with logCPM>1 in at least one sample were considered for analysis. Two 
models were used to test different aspects of genotype and treatment effects. When 
comparing groups within the same genotype, a nested analysis was performed. For 
comparisons across genotypes we used a non-nested model with crossed genotype-treatment 
groups. Both models used different gene dispersion estimates. The glmQLFit and 
glmQLFTest functions in the edgeR package were used to test the contrasts between models. 
The resulting P values were false discovery rate adjusted. 
6.19 STATISTICAL ANALYSIS (STUDY I-IV) 
Statistical analysis was performed using GraphPad Prism Software. All data sets including 
only 2 groups were analyzed with an Unpaired t test. When more than 2 groups were present, 
data sets were analyzed using one-way ANOVA followed by multiple comparisons tests with 
Tukey’s or Fisher’s Least Significant Difference test (a=0.05). Statistically significant 





7 RESULTS AND DISCUSSION 
This thesis aims to investigate the impact of genetic end environmental factors in intestinal 
inflammation. In study I and study II, we focused on the role of signaling induced by 
activation of dietary sensors in maintaining immune homeostasis. While for study I we 
examined its impact on the composition of the intestinal epithelial and immune cell 
compartments, in study II, we investigated how simultaneous activation of multiple receptors 
modulates cytokine production.  
In study III, we analyzed the impact of genetic susceptibility on intestinal inflammation and 
examined how signaling through GPR35, an IBD-risk gene, regulates intestinal immune 
homeostasis. 
In study IV, we investigated how exposure to PFAS modulate immune responses during 
early stages of inflammation and its effect on the intestinal barrier function. 
In this section, a brief summary of the main results and a discussion on their implications are 
presented. The figures presented in this section are shown in full in the corresponding 
manuscript. More details for each study can be found in the manuscripts attached to this 
thesis. 
7.1 RETINOIC ACID RECEPTOR SIGNALING IN THE INTESTINAL 
EPITHELIUM SHAPES IMMUNE HOMEOSTASIS AND EPITHELIAL CELL 
DIFFERENTIATION (STUDY I) 
Retinoic acid, a vitamin A metabolite, is sensed by retinoic acid receptors (RARs, -a, -b and -
g), which act as nuclear receptors modulating transcriptional responses 197. Retinoids have a 
profound role in the maintenance of immune homeostasis 258, being involved in several 
processes, such as inducing gut homing of B and T cells 213,214 and regulating the 
differentiation of intestinal dendritic cell subsets 210. Although retinoids are absorbed by 
intestinal epithelial cells in the small intestine, the effect of RAR signaling on these cells was 
unexplored. Thus, using genetically engineered mice in which RARa signaling was 
specifically deleted on IECs we investigated the effect of RA activation in the epithelial 
compartment and how this might affect intestinal homeostasis. In particular, we specifically 
targeted the RARa isoform within the epithelial compartment by crossing RARaf/f 
conditional mice with Villin-cre mice (RARaDvillin mice), which drives expression in 
intestinal epithelial cells 259. We then tested if the composition of the epithelial compartment 
was altered and observed that RARaDvillin mice had reduced numbers of enteroendocrine cells 
and increased numbers of goblet and Paneth cells in the small intestine, compared to controls, 
by immunohistochemistry. Notably, as the Cre recombinase was only expressed from the 
upper crypt section to the villi, we cannot exclude that RAR signaling might also modulate 
crypt progenitors. 
Considering that the differentiation of the secretory progenitors might be affected, we 
wondered if the expression of transcription factors that are necessary for their differentiation 
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into the different IEC lineages might be affected in the RARaDvillin mice. We focused on 
Kruppel-like factor 4 (KLF4), which has been reported as a regulator of goblet cell 
differentiation 260 and found increased numbers of KLF4+ cells in sections from the small 
intestine of RARaDvillin mice, compared to controls. Additionally, to examine if RAR 
activation would modulate Klf4 expression in vivo, we exposed zebrafish larvae to RA and 
found decreased klf4 transcript levels. Altogether, this suggests that RARa signaling 
modulates klf4 expression, which might be associated with aberrant goblet cell 
differentiation. 
We also found increased numbers of Paneth cells, which produce the vast majority of 
antimicrobial peptides (AMPs) in the GI tract. In agreement, we detected increased 
expression of AMPs produced by Paneth cells, including Ang4 and Reg3g by qPCR. Since 
AMPs can regulate bacterial colonization, we hypothesized that the microbiota composition 
could be altered. Indeed, we found a drastic reduction in the content of luminal microbiota by 
fluorescence in situ hybridization in the small intestine of RARaDvillin mice.  
Since it is well accepted that the microbiota shapes intestinal immune responses and we 
found that the RARaDvillin mice had alterations in the microbiota, we asked if this was also 
associated with changes in the composition of the immune cell compartment. We found that 
mononuclear phagocytes, including dendritic cells and macrophages, were reduced in mice 
where RARa signaling in IECs was impaired. Specifically, we performed the ALDEFLUOR 
assay 214 and found that intestinal dendritic cells with the ability to metabolize vitamin A into 
RA, were reduced in RARaDvillin mice, in comparison with their control counterparts. In 
addition, we found decreased frequencies of CD90+ lymphocytes and B220+ B cells in the 
colon lamina propria of RARaDvillin mice and lack of isolated lymphoid follicles, compared to 
control. In summary, lack of RARa signaling in IECs results in changes in the composition 
of the immune cell compartment. 
Having shown that RARa deficiency in IECs impaired immune homeostasis, we 
hypothesized that this could affect immune responses to infection. Infection with Citrobacter 
rodentium, a pathogen with similar properties to those of the human enteropathogenic 
Escherichia coli, leads to inflammation in the distal colon that is usually resolved by 
immunocompetent mice. We observed that RARaDvillin mice had a delayed pathogen 
clearance, increased bacterial translocation to the spleen and body weight loss. Altogether, 
RARa signaling in IECs has an important role in the maintenance of intestinal homeostasis. 
Here, we found that RARa signaling in IECs regulates the specification of secretory 
epithelial cells. Considering that it had a different effect on the distinct epithelial cell 
lineages, we can speculate that RARa could be involved in the differentiation towards each 
secretory cell type, but once progenitors have been committed to the secretory fate. Among 
the transcription factors that regulate the specification of secretory cells, we focused on Klf4, 
whose transcription has been shown to be modulated by RARa 261, and hence, it could be 
located upstream of Klf4 in the hierarchy of lineage commitment. 
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Overall, we observed that differences in the secretory epithelial cell differentiation as a result 
of a lack of RARa epithelial signaling were associated with changes in the composition of 
the immune cell compartment, which ultimately led to higher susceptibility to pathogen 
infection (Figure 6). This highlights the importance of adequate sensing of environmental 














7.2 SIMULTANEOUS ACTIVATION OF LIGAND-ACTIVATED TRANSCRIPTION 
FACTORS MODULATES CYTOKINE EXPRESSION (STUDY II) 
As a barrier organ, the intestinal epithelium is constantly exposed to a plethora of antigens, 
including dietary-derived metabolites, microbes, pathogens and harmful pollutants. Sensing 
of these environmental stimuli has a crucial role in the mounting of immune responses and 
hence, must be tightly controlled. Dietary-derived ligands, which comprise an important class 
of environmental stimuli, are sensed by ligand-activated transcription factors that are either 
present in the nucleus already bound to their response elements (e.g. nuclear receptors such as 
LXR and RAR), or present in the cytoplasm in an unliganded form (e.g. AHR). These 
receptors, individually, are known to have a profound influence in immune homeostasis 
258,262,263. However, the impact of their combinatorial activation in vivo is widely unexplored. 
This is particularly important, since tissues are continually exposed to combinations of 
compounds that might activate or inhibit several receptors simultaneously and we do not 
understand well the outcome of such combinatorial activation or inhibition. Testing the effect 
of several compounds simultaneously requires a complex experimental design including 
Figure 6. Scheme showing our main findings and the proposed model 1. Lack of RARɑ signaling in IEC affected the 
specification of the secretory lineages of epithelial cells and was associated with alterations in microbiota 
composition. The development of the intestinal immune system was also affected, as we found lymphoid organs of 
smaller size and reduced numbers of mononuclear phagocytes. ALDE: Aldefluor, SFB: Segmented filamentous 
bacteria, DC: dendritic cell, MO: macrophage. 
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many experimental conditions, and presents several logistical challenges including the 
administration route and readouts analyzed. Considering this and the high costs associated, it 
is not possible to perform these experiments in mice. Zebrafish, therefore, provides an 
excellent model system that can fill this gap for the following reasons. For example, the 
maintenance cost of zebrafish is substantially lower from that of mice, they have large clutch 
sizes and allow exposure by immersion. Therefore, we examined the effect of simultaneous 
activation of nuclear receptors and AHR in modulating immune responses in zebrafish larvae. 
Particularly, we examined cytokine production, especially those involved in the maintenance 
of immune homeostasis 264. 
We focused on AHR, LXR and RAR, which have been shown to regulate the production of 
cytokines, especially those relevant in immune mediated disorders 265. These receptors are 
conserved in zebrafish 266-270 and we first wondered if exposure to their ligands, would result 
in their activation. To address this, we analyzed the expression of target genes for each 
receptor by qPCR and found that exposure to each ligand resulted in increased expression of 
individual target genes. We next asked if the signaling of each receptor would be affected by 
simultaneous exposure to other ligands. We found that co-exposure with more than one 
ligand resulted in increased expression of the corresponding target genes, and to a similar 
level as when they were individually activated. Thus, indicating that there is no bystander 
interference upon specific receptor activation. 
Further, we examined how the expression of cytokines that regulate mucosal homeostasis 
264,271,272 was modulated by receptor activation in our model. We found that RA exposure 
resulted in increased expression of il1b, il17a/f3 and il22 and lower transcript levels of il10, 
suggesting a pro-inflammatory cytokine profile. Considering that ligand co-exposure resulted 
in simultaneous receptor activation, we tested whether treatment with a combination of 
ligands could result in differential expression of cytokines and found that AHR activation led 
to a reduction in the transcript levels of il17a/f3 and il22 levels induced by RA. Further, LXR 
activation counteracted the increased transcript levels of il17a/f3 following RA exposure, 
while co-activation of LXR and RAR resulted in a further decrease in il10 expression and 
increased expression of tnfa. In summary, simultaneous activation of ligand-activated 
transcription factors, such as LXR and RAR, results in a differential cytokine milieu from 
that of their individual activation (Figure 7). To our knowledge, most of our findings 
represent the first report of the modulation of cytokine expression in zebrafish larvae by the 
activation of these receptors.  
Previous reports in mouse models have focused on the impact of the signaling of these 
receptors in lymphocytes, such as the IL-22 production by ILCs 273 and the induction of Th17 
responses 274 promoted by RA signaling, which is in agreement with our findings. However, 
these cells do not exist at this developmental stage in zebrafish larvae. Thus, it is tempting to 
speculate that although the elicited responses are functionally conserved the cells that respond 














In addition, we found that while co-exposure with different ligands resulted in the induction 
of the corresponding target genes, without interfering in receptor activity, it resulted in 
modulation of the cytokine expression. We can speculate that the crosstalk between these 
receptors might happen further downstream, e.g., binding to DNA response elements or 
activation of downstream pathways. However, this still remains unclear, and a better 
understanding of this would aid in the design of therapies considering combinatorial 
approaches. 
An important point to highlight is that the cytokine profile induced by the activation of these 
receptors is markedly affected by the in vitro or animal model and the ligand and 
concentration used, such as opposite effects in IL-17 production being reported for AHR 
agonists 199. Although our results have the potential to be translated to mammals, the 
conservation of the immune responses should be examined in the corresponding model. 
Finally, to our knowledge, this is the first study aimed to understand the impact of the 
combinatorial activation of ligand-activated transcription factors in immune responses in an 
in vivo context. Considering the advantages of an approach based on a whole organism as 
opposed to in vitro studies, i.e. the complexity of a vertebrate organ system and presence of 
different cell types, we believe that this could represent a powerful screening platform that 
could accelerate drug discovery and testing of therapeutic targets. 
7.3 ROLE OF GPR35 SIGNALING IN THE MAINTENANCE OF INTESTINAL 
IMMUNE HOMEOSTASIS (STUDY III) 
In the third manuscript included in this thesis we shifted the focus from environmental factors 
to genetics in the development of intestinal inflammation. Genome-wide association studies 
(GWAS) have identified more than 200 IBD-risk loci 105, including single-nucleotide 
polymorphisms in GPR35 102,114. Recently it has been shown that Gpr35 deficiency results in 
Figure 7. Summary scheme of the modulation of cytokine expression by environmental sensors. Dietary-derived 
ligands can activate transcription factors, such as AHR and NRs, including LXR and RAR. Combinatorial 
receptor activation can result in synergistic or antagonistic regulation of immune responses. Modified from 4. 
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reduced IEC turnover and worsened chemically induced colitis 119,120 However, the role of 
GPR35 signaling in the initiation and/or progression of intestinal inflammation and the 
underlying mechanism is yet to be understood. In this study, we identified lysophosphatidic 
acid (LPA) as a potential endogenous ligand of GPR35, which controls intestinal 
inflammation by maintaining TNF-mediated homeostasis, by using a combination of 
zebrafish and mouse models. 
To investigate the role of GPR35 in intestinal homeostasis, we first characterized the 
expression of its orthologs in zebrafish (gpr35b) and mice (Gpr35) and found the highest 
transcript levels in the gastrointestinal tract, similar to what had been described in the Human 
Protein Atlas 275 (available from http://www.proteinatlas.org), indicating conservation in its 
expression pattern, from zebrafish to humans.  
Considering that G-protein coupled receptors is an IBD-risk locus with expression mostly 
restricted to the intestine, we hypothesized that GPR35 expression could be modulated by the 
intestinal milieu. To analyze if Gpr35 expression was dependent on the microbiota, we 
treated mice and zebrafish with antibiotics and found that its expression was reduced 
compared to non-treated controls. Moreover, to address if GPR35 expression would be 
modulated by inflammation, we used several models of intestinal inflammation in zebrafish 
larvae and mice and consistently found increased transcript levels in the intestine. Finally, to 
test the clinical relevance of our findings, we also found increased number of GPR35+ cells in 
the lamina propria of biopsies from inflamed areas in patients with ulcerative colitis, 
compared to non-inflamed regions. Altogether, this indicates that GPR35 expression is 
microbiota dependent and increased upon inflammation. 
The endogenous ligand of GPR35 that could modulate immune responses in the intestine 
remains unknown. To address this, we performed an in vitro screening of suspected GPR35 
ligands and found that LPA would activate this receptor. To test the specificity of LPA as a 
GPR35 ligand in vivo, we generated a GPR35 mutant zebrafish and mouse lines. We found 
that LPA treatment induced expression of pro-inflammatory cytokines, such as Tnf, in a 
GPR35-dependent manner. We then hypothesized that production of LPA, which can act as a 
signaling molecule, could be induced in the context of inflammation. Indeed, we detected 
increased LPA levels in the supernatant of colonic explants from colitic mice, indicating that 
this molecule is produced during inflammation. 
Considering that LPA production is induced during inflammation and that it modulates 
cytokine production, we next asked if Gpr35 signaling might affect intestinal inflammation. 
We observed that Gpr35-deficient mice developed exacerbated DSS-induced colitis, in terms 
of increased body weight loss and increased histological scores. Since Gpr35 was expressed 
in CX3CR1+ macrophages, and its expression in these cells increased during inflammation, 
we wondered if the worsened colitis could be due to an intrinsic effect on macrophages. To 
test this, we crossed conditional Gpr35f/f mice with Cx3cr1CreER, where Gpr35 would be 
deleted in Cx3cr1-expressing cells upon tamoxifen administration. These mice, termed 
Gpr35DCx3cr1, had an aggravated colitis, compared to control groups. 
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We then administered LPA to mice undergoing colitis and found that wild-type developed a 
milder colitis, while Gpr35DCx3cr1 did not respond, indicating that the LPA-mediated effect is 
Gpr35-dependent. Gpr35DCx3cr1 mice also had reduced frequencies of TNF-producing 
macrophages, detected by flow cytometry. Although TNF is mostly known for its pro-
inflammatory role, its deficiency results in exacerbated colitis and reduced corticosterone 
production, which can suppress inflammation 276. Thus, we hypothesized that TNF 
administration could ameliorate colitis severity. Accordingly, this treatment resulted in less 
severe colitis and restored the low levels of corticosterone found in the colon Gpr35DCx3cr1 
mice. Overall, these results indicate that impaired signaling of Gpr35 in macrophages led to 
their reduced production of TNF which was associated with decreased corticosterone 
synthesis and aggravated colitis, which was counteracted by TNF administration. 
Finally, to better understand the effect of an IBD-associated variant, we focused on 
rs3749171, that results in a T108M substitution and represents a hypermorphic allele 119. By 
analyzing patients enrolled in the Swiss IBD Cohort Study, we found that the hyperactive 
GPR35 variant was associated with a higher percentage of patients responding to anti-TNF 
therapy. We speculate that patients harboring this mutation might have increased TNF 
production and the enhanced inflammatory response could be ameliorated with TNF 
blockers. 
In this study, we have shown a conservation in the expression pattern of GPR35 from 
zebrafish to humans at steady state and under environmental stimuli. Further, immune 
responses mediated by LPA in a GPR35-dependent manner were conserved in zebrafish and 
mice (Figure 8). Moreover, as the list of ligands for GPR35, remains to be fully identified, 
we believe that further screenings to characterize their potency and affinity in different 











Figure 8. Scheme showing the proposed model of the effect of LPA-mediated GPR35 signaling in the 
maintenance of intestinal homeostasis 3. Environmental cues modulated GPR35 expression in zebrafish and mice. 
GPR35 signaling in macrophages induced their production of TNF and synthesis of corticosterone, which 




7.4 PFOS EXPOSURE EXACERBATES NEUTROPHIL-MEDIATED INTESTINAL 
INFLAMMATION AND PROMOTES SYSTEMIC T CELL RESPONSES 
(STUDY IV) 
In the last study included in this thesis we examined how exposure to environmental 
pollutants modulates intestinal inflammation. Among environmental pollutants, per- and 
polyfluoroalkyl substances (PFAS) represent a class of highly persistent chemicals of 
anthropogenic origin, that are present worldwide. Several health concerns have been 
associated to PFAS exposure and effects on the immune system are considered critical for the 
risk assessment for this class of pollutants 277. While exposure to PFAS has been positively 
associated with incidence of ulcerative colitis and to affect clearance of an infection of an 
intestinal pathogen 165,175, how they affect early stages of intestinal inflammation and 
epithelial barrier function is largely unclear. To investigate this, we used an established model 
of chemically induced intestinal inflammation in zebrafish larvae and mice exposed to these 
pollutants. 
Shorter-chain length PFAS are considered to bioaccumulate less than their longer-chain 
counterparts (such as perfluorooctane sulfonic acid (PFOS)) 139, and have in turn, partially 
replaced the use of the latter in products. However, little is known about their 
immunomodulatory properties. To examine this, we exposed zebrafish larvae undergoing 
TNBS-induced inflammation to several PFAS and found that PFOS exacerbated the 
expression of il1b, a proinflammatory cytokine, in whole larvae, detected by qPCR. We then 
confirmed, by dissecting the gastrointestinal tract, that the induction of il1b expression was 
intestine-specific. Another hallmark of intestinal inflammation in mammals is increased 
neutrophil recruitment. By using neutrophil-specific transgenic zebrafish we found increased 
numbers of neutrophils in the intestine of larvae exposed to PFOS while undergoing colitis. 
Overall, this indicates that PFOS exacerbates intestinal inflammation in zebrafish larvae. 
We then asked if the enhanced neutrophil recruitment to the intestine was recapitulated in 
mammals, in the corresponding TNBS colitis model in mice. In agreement, we observed that 
oral PFOS exposure prior and during induction of colitis resulted in increased neutrophil 
infiltration to the colon, analyzed 3 days after TNBS administration using flow cytometry. 
This was associated with increased histological score and body weight loss, indicative of a 
worsened colitis. 
Considering that PFOS bioaccumulate in tissues due to limited clearance and that oral 
exposure remains the main route of intake 145, we tested whether its bioavailability was 
affected in the context of intestinal inflammation. We detected increased levels of this 
pollutant in the serum and liver of mice that were exposed to it while undergoing colitis. In 
view of this, we hypothesized that the function of the intestinal barrier might be affected by 
PFAS exposure during inflammation. To address this, we performed a FITC-Dextran 
permeability assay at different timepoints, and found that, within 24 hours of colitis 
induction, PFOS exposure results in increased permeability compared to TNBS alone. 
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Further, at day 3 post TNBS administration, mice that were co-exposed to TNBS-PFOS still 
showed a trend of increased permeability, indicating that PFOS exposure in the context of 
intestinal inflammation affects intestinal permeability. 
Interestingly, there was a similar initial increase in neutrophils 24 hours after colitis 
induction, and while numbers still remained high at 3 days after TNBS administration in mice 
that were given PFOS, levels had almost returned to baseline in mice that were not exposed. 
This suggests that PFOS sustains neutrophils in the colon following a challenge. Neutrophil 
presence in damaged tissues must be tightly controlled by their timely removal to allow the 
resolution of the inflammation 278. We then wondered if the impairment in the epithelial 
barrier function was affected by the enhanced neutrophil infiltration. To test this, we used a 
neutrophil depleting antibody and found that permeability decreased to levels similar to those 
found in mice solely exposed to PFOS. Thus, suggesting that the disruption of the intestinal 
barrier function is partially affected by the increased neutrophil influx. Altogether, we 
propose a model where PFOS exposure in the context of intestinal inflammation enhances 
neutrophil recruitment and leads to an impairment in barrier integrity and translocation of this 
pollutant into circulation. 
Finally, we wondered if the increased PFOS levels systemically, found in the context of 
intestinal inflammation, could have an effect on the composition of the immune cell 
compartment in periphery. We then examined the spleen and found that PFOS exposure 
during colitis resulted in an increase of CD45+ (immune) cells, and in particular, CD4+ T 
cells. Since this was associated with an increase in neutrophil numbers in the colon of colitic 
mice exposed to PFOS, we tested if the increase of cellularity in the spleen was neutrophil-
dependent. Following neutrophil depletion, we found that both the number of total CD45+ 
cells and CD4+ T cells were reduced to levels close to the baseline. Overall, we speculate that 
this neutrophil dependent splenic CD4+ T cell expansion could be partially due to the 
increased systemic bioavailability of PFOS and/or inflammatory signals resulting from the 
exacerbated intestinal inflammation. 
In summary, by using zebrafish larvae and mice we showed that PFOS exacerbates 
chemically induced intestinal inflammation. Moreover, our findings indicate that the effects 
of PFOS exposure during colitis are not only restricted to the intestine, as we also found an 
expansion of CD4+ T cells in the spleen (Figure 9). Finally, we believe that this study 
highlights the relevance of the zebrafish as a model to test the immunomodulatory properties 




















Figure 9. Scheme showing the proposed model. PFOS exposure during intestinal inflammation 
results in increased neutrophil recruitment to the gastrointestinal tract and intestinal permeability. This 
is also associated with increased systemic bioavailability of the pollutant and an expansion of T cells 




The findings of this thesis have provided insight into how intestinal inflammation is 
influenced by genetic susceptibility and exposure to environmental elements. However, 
several questions remain unanswered and should be the focus of future studies. 
Particularly, we used zebrafish as a model to investigate how intestinal homeostasis is 
regulated in different contexts and subsequently validated some of our results in mammals. 
This highlights the relevance of the zebrafish model in the study of intestinal immunity. In 
addition, we provided evidence that this model could also be used to examine the interaction 
between genetic and environmental factors and their impact on intestinal inflammation.  
However, many questions remain regarding the composition of the zebrafish immune system 
and the source of different immune modulators and signaling molecules, such as cytokines. 
Therefore, a more complete characterization of the zebrafish system, not only during the 
larval stage but also during adulthood, by using single-cell RNA techniques, for example, 
would greatly help in the establishment of this model in the immunology field.  
In study I, we found that epithelial RARa signaling contributes to the specification of 
epithelial cells and has profound implications in the development and function of the 
intestinal immune system. This highlights an understudied role of how signals originating 
from non-immune cells impact intestinal immunity. In this study, RARavillin mice were 
analyzed at 8 to 12 weeks, and RARa signaling was impaired during their development. 
Thus, we could speculate that alterations in vitamin A sensing might have a different impact 
in mice with a mature immune system. A better understanding of the effect of RAR signaling 
in adult mice (e.g. using a tamoxifen inducible VillinCreERT2) would be essential. 
In study II, we showed that simultaneous activation of NRs and AHR can induce a distinct 
cytokine profile. We believe that combinatorial approaches could aid in the design of 
interventions to tailor specific immune responses. Moreover, since whole larvae are exposed 
to the ligands, this represents a valuable platform that can be used to examine the response 
induced in different tissues simultaneously. 
In study III, we found that GPR35 contributes to the maintenance of intestinal homeostasis 
and identified LPA as a potential endogenous ligand for GPR35. However, which host cell 
produces LPA and if this would differ depending on the context still remains to be addressed. 
Moreover, considering that LPA can be sensed by other LPA receptors, it is possible that 
other endogenous ligands are activating GPR35 in our system. Finally, further screenings to 
identify additional GPR35 ligands and a more profound characterization of its function is 
essential for its possible use as therapeutical target. 
In study IV, we found how exposure to a globally distributed pollutant affects early stages of 
intestinal inflammation and affects systemic immune responses. We found increased 
neutrophil recruitment to the gastrointestinal tract in zebrafish and mice, which emphasizes 
the relevance of zebrafish larvae to study innate immunity. However, what do these 
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neutrophils produce and what mediators regulate their recruitment? Answering these 
questions would be crucial to establish therapies targeting neutrophil-driven intestinal 
inflammation.  
Considering our findings in the context of the wide distribution and persistence of PFAS, it is 
imperative to regulate and restrict their use and functionally characterize the 
immunomodulatory properties of shorter-chain length PFAS that are currently substituting 
the longer-chain length compounds. In this same manner, although beyond the scope of this 
thesis, the importance of designing novel techniques for the challenging remediation of PFAS 
are in urgent need. 
In summary, by using mice and zebrafish models we have gained greater understanding into 
the effect of environmental triggers and genetic susceptibility in intestinal inflammation. We 
believe that incorporating both models can accelerate the identification of novel ligands, test 
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